Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News Complete Archive »

Musculoskeletal News Roundup 11-Sept-08 BY LAUREN UZDIENSKI, SEPTEMBER 11, 2008

Wright Medical Group, Inc. acquired the RAYHACK System for wrist reconstruction, which consists of "procedure-specific bone-cutting guides and fixation plates that allow precise shortening and repositioning of the radius and ulna." The system will be available in the U.S. immediately and internationally in early 2009. Financial terms were not disclosed.

Innovative Spinal Technologies raised $18.0 million in a series C round of funding. Participating investors were not disclosed.

Arthrosurface received FDA approval to begin its pivotal investigation evaluating its HemiCAP implants for the treatment of focal femoral condyle defects. Matthias R. Schurhoff, MD, Vice President of Clinical Operations and Scientific Affairs, said of the IDE feasibility study, "We are very pleased with our two-year results . . . our data has demonstrated remarkable improvement in pain and function in a challenging middle-aged patient population."

Orthofix announced 510(k) clearance for the PILLAR SA spine interbody device, which the company expects to be available in the U.S. next year. Additionally, the company received a Notification of Approval to market the CentroNail family of nailing systems in Japan. The CentroNail line includes both tibial and femoral intramedullary nails.

StemCor Systems received the CE Mark for its MarrowMiner System, a minimally invasive device used to harvest adult stem cells. The company says the product's applications include "accelerating bone healing in spinal fusions and other orthopedic procedures."

aap bio implant has entered into an agreement with Zimmer whereby Zimmer will distribute the EASYMIX and EASYMIX PRO vacuum mixing systems in Europe and other international markets.

ThermoGenesis and Celling Technologies have signed a five-year agreement whereby Celling will distribute ThermoGenesis's MarrowXpress product line, which is used for isolating stem cells from bone marrow. The distribution rights are for the product's use in orthopedic intraoperative or point-of-care applications.

Spinal Restoration completed enrollment for its IDE pilot study of the Biostat Disc Augmentation System for the treatment of chronic discogenic pain associated with IDD. The system consists of BIOSTAT BIOLOGX Fibrin Sealant and a proprietary application system designed to deliver the biologic to the intervertebral disc. The company expects six-month results from this three-site, 15-patient study to be available in early 2009.

On September 16th, Biomet will host the grand opening of its new $3.5 million Orthopaedic Skills Academy, which occupies 27,000 square feet of remodeled space with two instructional labs and a 48-seat auditorium and is intended for the training of surgeons and salespeople. The event will feature Biomet spokeswoman Mary Lou Retton, a former Olympic gymnast and joint replacement patient.

Orthofix announced the appointment of Robert S. Vaters as Executive Vice President and Chief Financial Officer. Previously, Mr. Vaters served as Executive Vice President, Chief Financial Officer and Head of Strategy and Corporate Development at Inamed Corporation until it was acquired by Allergan Inc. in March of 2006. Acting Orthofix CFO Tom Hein will assume the role of Executive Vice President of Finance.

Email this to a colleague: